295 related articles for article (PubMed ID: 36901699)
1. Prader-Willi Syndrome and Chromosome 15q11.2 BP1-BP2 Region: A Review.
Butler MG
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901699
[TBL] [Abstract][Full Text] [Related]
2. The 15q11.2 BP1-BP2 Microdeletion (
Rafi SK; Butler MG
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32384786
[TBL] [Abstract][Full Text] [Related]
3. Magnesium Supplement and the 15q11.2 BP1-BP2 Microdeletion (Burnside-Butler) Syndrome: A Potential Treatment?
Butler MG
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31207912
[TBL] [Abstract][Full Text] [Related]
4. Prader-Willi syndrome, deletion subtypes, and magnesium: Potential impact on clinical findings.
Butler MG; Cowen N; Bhatnagar A
Am J Med Genet A; 2022 Nov; 188(11):3278-3286. PubMed ID: 36190479
[TBL] [Abstract][Full Text] [Related]
5. Genomic analysis of the chromosome 15q11-q13 Prader-Willi syndrome region and characterization of transcripts for GOLGA8E and WHCD1L1 from the proximal breakpoint region.
Jiang YH; Wauki K; Liu Q; Bressler J; Pan Y; Kashork CD; Shaffer LG; Beaudet AL
BMC Genomics; 2008 Jan; 9():50. PubMed ID: 18226259
[TBL] [Abstract][Full Text] [Related]
6. Nine patients with a microdeletion 15q11.2 between breakpoints 1 and 2 of the Prader-Willi critical region, possibly associated with behavioural disturbances.
Doornbos M; Sikkema-Raddatz B; Ruijvenkamp CA; Dijkhuizen T; Bijlsma EK; Gijsbers AC; Hilhorst-Hofstee Y; Hordijk R; Verbruggen KT; Kerstjens-Frederikse WS; van Essen T; Kok K; van Silfhout AT; Breuning M; van Ravenswaaij-Arts CM
Eur J Med Genet; 2009; 52(2-3):108-15. PubMed ID: 19328872
[TBL] [Abstract][Full Text] [Related]
7. Identification of four highly conserved genes between breakpoint hotspots BP1 and BP2 of the Prader-Willi/Angelman syndromes deletion region that have undergone evolutionary transposition mediated by flanking duplicons.
Chai JH; Locke DP; Greally JM; Knoll JH; Ohta T; Dunai J; Yavor A; Eichler EE; Nicholls RD
Am J Hum Genet; 2003 Oct; 73(4):898-925. PubMed ID: 14508708
[TBL] [Abstract][Full Text] [Related]
8. Clinical and genetic aspects of the 15q11.2 BP1-BP2 microdeletion disorder.
Butler MG
J Intellect Disabil Res; 2017 Jun; 61(6):568-579. PubMed ID: 28387067
[TBL] [Abstract][Full Text] [Related]
9. Expression of 4 genes between chromosome 15 breakpoints 1 and 2 and behavioral outcomes in Prader-Willi syndrome.
Bittel DC; Kibiryeva N; Butler MG
Pediatrics; 2006 Oct; 118(4):e1276-83. PubMed ID: 16982806
[TBL] [Abstract][Full Text] [Related]
10. Genomic, Clinical, and Behavioral Characterization of 15q11.2 BP1-BP2 Deletion (Burnside-Butler) Syndrome in Five Families.
Baldwin I; Shafer RL; Hossain WA; Gunewardena S; Veatch OJ; Mosconi MW; Butler MG
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562221
[TBL] [Abstract][Full Text] [Related]
11. Array comparative genomic hybridization (aCGH) analysis in Prader-Willi syndrome.
Butler MG; Fischer W; Kibiryeva N; Bittel DC
Am J Med Genet A; 2008 Apr; 146A(7):854-60. PubMed ID: 18266248
[TBL] [Abstract][Full Text] [Related]
12. Detection of a novel familial deletion of four genes between BP1 and BP2 of the Prader-Willi/Angelman syndrome critical region by oligo-array CGH in a child with neurological disorder and speech impairment.
Murthy SK; Nygren AO; El Shakankiry HM; Schouten JP; Al Khayat AI; Ridha A; Al Ali MT
Cytogenet Genome Res; 2007; 116(1-2):135-40. PubMed ID: 17268193
[TBL] [Abstract][Full Text] [Related]
13. Advances in genetic mechanisms of hypothalamic dysfunction in Prader-Willi syndrome.
Wang XY; Sun R; Gao YQ
Yi Chuan; 2022 Oct; 44(10):899-912. PubMed ID: 36384726
[TBL] [Abstract][Full Text] [Related]
14. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria.
Gunay-Aygun M; Schwartz S; Heeger S; O'Riordan MA; Cassidy SB
Pediatrics; 2001 Nov; 108(5):E92. PubMed ID: 11694676
[TBL] [Abstract][Full Text] [Related]
15. The 15q11.2 BP1-BP2 microdeletion syndrome: a review.
Cox DM; Butler MG
Int J Mol Sci; 2015 Feb; 16(2):4068-82. PubMed ID: 25689425
[TBL] [Abstract][Full Text] [Related]
16. Treatment-resistant psychotic symptoms and the 15q11.2 BP1-BP2 (Burnside-Butler) deletion syndrome: case report and review of the literature.
Farrell M; Lichtenstein M; Harner MK; Crowley JJ; Filmyer DM; Lázaro-Muñoz G; Dietterich TE; Bruno LM; Shaughnessy RA; Biondi TF; Burkholder S; Donmoyer J; Berg JS; Szatkiewicz J; Sullivan PF; Josiassen RC
Transl Psychiatry; 2020 Jan; 10(1):42. PubMed ID: 32066678
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and magnesium levels: Novel insights in 15q11.2 BP1-BP2 copy number variants.
Meossi C; Carrer A; Ciaccio C; Estienne M; Silipigni R; Sciacca FL; Pantaleoni C; D'Arrigo S; Milani D
J Intellect Disabil Res; 2023 Jul; 67(7):679-689. PubMed ID: 37129092
[TBL] [Abstract][Full Text] [Related]
18. Prenatal diagnosis of a familial 15q11.2 (BP1-BP2) microdeletion encompassing TUBGCP5, CYFIP1, NIPA2 and NIPA1 in a fetus with ventriculomegaly, microcephaly and intrauterine growth restriction on prenatal ultrasound.
Chen CP; Chang SY; Wang LK; Chang TY; Chern SR; Wu PS; Chen SW; Lai ST; Chuang TY; Yang CW; Town DD; Chen LF; Wang W
Taiwan J Obstet Gynecol; 2018 Oct; 57(5):730-733. PubMed ID: 30342661
[TBL] [Abstract][Full Text] [Related]
19. Behavioral differences among subjects with Prader-Willi syndrome and type I or type II deletion and maternal disomy.
Butler MG; Bittel DC; Kibiryeva N; Talebizadeh Z; Thompson T
Pediatrics; 2004 Mar; 113(3 Pt 1):565-73. PubMed ID: 14993551
[TBL] [Abstract][Full Text] [Related]
20. Prader-Willi syndrome and atypical submicroscopic 15q11-q13 deletions with or without imprinting defects.
Hassan M; Butler MG
Eur J Med Genet; 2016 Nov; 59(11):584-589. PubMed ID: 27659713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
